Taia T. Wang, Ph.D.
Affiliations: | 2010 | Microbiology | Icahn School of Medicine at Mount Sinai, New York, NY, United States |
Area:
Microbiology Biology, Immunology, Virology BiologyGoogle:
"Taia Wang"Parents
Sign in to add mentor| Thomas Moran | grad student | 2010 | Mount Sinai School of Medicine | |
| (Structural determinants of influenza virus neutralization.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ashraf U, Lee A, Gao Q, et al. (2025) Impact of age and prior COVID-19 on the response to influenza a components in the 2020-2021 Fluzone vaccine. Vaccine. 56: 127171 |
| Mallajosyula V, Chakraborty S, Sola E, et al. (2024) Coupling antigens from multiple subtypes of influenza can broaden antibody and T cell responses. Science (New York, N.Y.). 386: 1389-1395 |
| Chakraborty S, Cheng BY, Edwards DL, et al. (2024) Sialylated IgG induces the transcription factor REST in alveolar macrophages to protect against lung inflammation and severe influenza disease. Immunity |
| Arunachalam PS, Feng Y, Ashraf U, et al. (2022) Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccine. Science Translational Medicine. 14: eabq4130 |
| Chakraborty S, Gonzalez JC, Sievers BL, et al. (2022) Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity. Science Translational Medicine. eabm7853 |
| Sievers BL, Chakraborty S, Xue Y, et al. (2022) Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses. Science Translational Medicine. eabn7842 |
| González JC, Wang TT. (2021) Illuminating the Fc dependence of SARS-CoV-2 neutralization. Immunity |
| Chakraborty S, Gonzalez JC, Sievers BL, et al. (2021) Divergent early antibody responses define COVID-19 disease trajectories. Biorxiv : the Preprint Server For Biology |
| Chakraborty S, Mallajosyula V, Tato CM, et al. (2021) SARS-CoV-2 vaccines in advanced clinical trials: where do we stand. Advanced Drug Delivery Reviews |
| Röltgen K, Powell AE, Wirz OF, et al. (2020) Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome. Science Immunology. 5 |